A New Strategy for the Synthesis of 4‐Propargyl‐Substituted 1 H ‐Pyrroles from N ‐(5‐phenyl‐2,4‐pentadiynyl) β‐Enaminones-Reference-Cited by-同舟云学术

A New Strategy for the Synthesis of 4‐Propargyl‐Substituted 1 H ‐Pyrroles from N ‐(5‐phenyl‐2,4‐pentadiynyl) β‐Enaminones

Published:2019-10-09 Issue:37 Volume:4 Page:11043-11047
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Yilmaz Elif Serel¹,Zora Metin¹^ORCID

Affiliation:

1. Department of ChemistryMiddle East Technical University 06800 Ankara Turkey

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.201902759

Reference94 articles.

2. M. d'Ischia A. Napolitano A. Pezzella B. A. Trofimov N. A. Nedolya J. Bergman T. Janosik inComprehensive Heterocyclic Chemistry III; (Eds.: A. R. Katritzky C. A. Ramsden E. F. V. Scriven R. J. K. Taylor G. Jones) Pergamon-Elsevier: Oxford 2008; Vol. 3 pp 1–388 (Chapters 3.01-3.04).

3. L. D. Quin J. A. Tyrell Fundamentals of Heterocyclic Chemistry; Wiley: New Jersey 2010; pp 222–225 (Chapter 9.2).

4. J. Bergman T. Janosik inModern Heterocyclic Chemistry; (Eds.: J. Alvaroz-Builla J. J. Vaquero J. Barluenga) Wiley-VCH: Weinheim 2011; Vol. 4 pp 269–375 (Chapter 4).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N‐Propargylic β‐enaminones in breast cancer cells: Cytotoxicity, apoptosis, and cell cycle analyses;Journal of Biochemical and Molecular Toxicology;2023-01-16

2. A facile synthesis of a novel family of heterotricyclic hybrids: Spiro-pyrrolopyridazines;Synthetic Communications;2022-01-08

3. Recent Advances in Synthesis and Reactions of β-Amino-α ,β -Enones (Enaminones);Current Organic Synthesis;2021-10-26

4. Base‐Promoted Synthesis of 3‐Alkenyl ‐2‐pyridones from N ‐Propargyl ‐β‐enaminones and Aryl Aldehydes;Chinese Journal of Chemistry;2021-08-09

5. 4‐Propargyl‐substituted 1 H ‐pyrroles induce apoptosis and autophagy via extracellular signal‐regulated signaling pathway in breast cancer;Archiv der Pharmazie;2021-06-24